Cost-Effectiveness of Nepafenac 3 Mg/Ml for the Reduction in Risk of Post-Operative Macular Oedema Associated with Cataract Surgery- From UK NHS Perspective
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1289
https://www.valueinhealthjournal.com/article/S1098-3015(16)32655-9/fulltext
Title :
Cost-Effectiveness of Nepafenac 3 Mg/Ml for the Reduction in Risk of Post-Operative Macular Oedema Associated with Cataract Surgery- From UK NHS Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32655-9&doi=10.1016/j.jval.2016.09.1289
First page :
A569
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1206